A Review of Candidate Pathways Underlying the Association Between Asthma and Major Depressive Disorder
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Objective: To consider the mechanisms that may link asthma and major depressive disorder (MDD). Asthma and MDD co-occur at higher rates than expected, but whether this reflects shared underlying pathophysiological mechanisms is not known. Methods: A review of the epidemiological data linking asthma and MDD was conducted and the possible biological mechanisms that could account for the high rate of this comorbidity were reviewed. Results: MDD occurs in almost half of patients with asthma assessed in tertiary care centers. Dysregulation of the hypothalamic pituitary adrenal axis may predispose people to both MDD and asthma, and similar alterations in the immune, autonomic nervous, and other key systems are apparent and may contribute to this increased risk of co-occurrence. Conclusions: High rates of MDD in asthma may result from the stress of chronic illness, the medications used to treat it, or a combination of the two. The high level of co-occurrence may also reflect dysregulation of certain stress-sensitive biological processes that contribute to the pathophysiology of both conditions. ANS = autonomic nervous system; CD4 = cluster of differentiation 4; COX = cyclooxygenase; COX-2 = cyclooxyenase-2; CRH = corticotrophin-releasing hormone; GC = glucocorticoid; GR = glucocorticoid receptor; HPA = hypothalamic pituitary adrenal; ICAM-1 = intracellular adhesion molecule-1; IDO = indoleamine-2,3-dioxygenase; IgE = immunoglobulin E; IL = interleukin; MDD = major depressive disorder; NFkB = nuclear factor kappa B; NKA = neuropeptides; NO = nitric oxide; PDE4 = phosphodiesterase-4; PG = prostaglandin; PGE2 = prostaglandin E2; Th2 = Type 2 T-helper cell; TNF = tumor necrosis factor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
Adipose tissue, adipokines, and inflammation
Fantuzzi, G. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.02.023 · Cited by 2,606 · cited 1×
“Adipose tissue generates a systemic inflammatory milieu (35) that may increase the risk of diseases including asthma and MDD.”
BackgroundEder, W., Ege, M. J., & von Mutius, E. (2006) · New England Journal of Medicine · doi:10.1056/nejmra054308 · Cited by 1,621
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment
Pariante, C. M., & Miller, A. H. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01088-x · Cited by 1,147 · cited 2×
“GC signaling defects are present in depressed patients (55) as nearly 50% of persons with MDD have elevated cortisol levels (53) and a substantial number demonstrate evidence of cortisol nonsuppression in the dexamethasone suppression test as well as the more sensitive dexamethasone-CRH test (9).”
BackgroundSpatz Widom, C., DuMont, K., & Czaja, S. J. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.1.49 · Cited by 1,059 · cited 1×
“Children exposed to adverse psychosocial conditions are not only at risk of developing MDD (29) but asthma as well (30).”
BackgroundThe Relationship of Depression and Stressors to Immunological Assays: A Meta-Analytic Review
Zorrilla, E. P., Luborsky, L., McKay, J. R., Rosenthal, R., Houldin, A., Tax, A., McCorkle, R., Seligman, D. A., & Schmidt, K. (2001) · Brain, Behavior, and Immunity · doi:10.1006/brbi.2000.0597 · Cited by 995 · cited 1×
“IL-1ß is increased in those with asthma (69) and depression (70) and alters monoamine and neuropeptide metabolism (71).”
BackgroundToward a comprehensive developmental model for major depression in women
Kendler, K. S., Gardner, C. O., & Prescott, C. A. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.7.1133 · Cited by 962
Meaney, M. J., & Szyf, M. (2005) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2005.7.2/mmeaney · Cited by 958
Nuclear factor-?B: its role in health and disease
Kumar, A., Takada, Y., Boriek, A., & Aggarwal, B. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0555-y · Cited by 933
A mechanism converting psychosocial stress into mononuclear cell activation
Bierhaus, A., Wolf, J., Andrassy, M., Rohleder, N., Humpert, P. M., Petrov, D., Ferstl, R., von Eynatten, M., Wendt, T., Rudofsky, G., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0438019100 · Cited by 927
McKay, L. I., & Cidlowski, J. A. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.4.0375 · Cited by 805 · cited 1×
“Under these circumstances, intracellular glucocorticoid binding regulates immune responses by stabilizing nuclear factor kappa B (NFkB), a major effector of inflammatory responses in the body (51).”
BackgroundMüller, N., Schwarz, M. J., Dehning, S., Douhe, A., Cerovecki, A., Goldstein-Müller, B., Spellmann, I., Hetzel, G., Maino, K., Kleindienst, N., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001805 · Cited by 794
Pace, T. W. W., Hu, F., & Miller, A. H. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2006.08.009 · Cited by 621
Association of depression with medical illness: Does cortisol play a role?
Brown, E. S., Varghese, F. P., & McEwen, B. S. (2004) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00473-6 · Cited by 578 · cited 1×
“GC signaling defects are present in depressed patients (55) as nearly 50% of persons with MDD have elevated cortisol levels (53) and a substantial number demonstrate evidence of cortisol nonsuppression in the dexamethasone suppression test as well as the more sensitive dexamethasone-CRH test (9).”
BackgroundWebster, J. C., Oakley, R. H., Jewell, C. M., & Cidlowski, J. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121455098 · Cited by 482
Furey, M. L., & Drevets, W. C. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.10.1121 · Cited by 417 · cited 1×
“Others have suggested that MDD is associated with autonomic dysregulation in the form of cholinergic dominance (41,42) and the anticholinergic agent scopolamine has recently demonstrated rapid and potent antidepressant effects in depressed patients (43).”
BackgroundSympathetic activity in major depressive disorder: identifying those at increased cardiac risk?
Barton, D. A., Dawood, T., Lambert, E. A., Esler, M. D., Haikerwal, D., Brenchley, C., Socratous, F., Kaye, D. M., Schlaich, M. P., Hickie, I., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e32829baae7 · Cited by 291
Keller, M., Montgomery, S., Ball, W., Morrison, M., Snavely, D., Liu, G., Hargreaves, R., Hietala, J., Lines, C., Beebe, K., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.07.013 · Cited by 286 · cited 1×
“As a result, they have become attractive targets for therapeutic manipulation in mood disorders and antagonists of NK1 have demonstrated some efficacy in treating depression (113) although results are mixed (114).”
ResultTobacco smoking and depressed mood in late childhood and early adolescence.
Wu, L. T., & Anthony, J. C. (1999) · American Journal of Public Health · doi:10.2105/ajph.89.12.1837 · Cited by 273 · cited 1×
“Cigarette smoking in utero is a physiologic stress proposed to be a risk factor for MDD (23) and asthma (24) in offspring.”
BackgroundThe Physiology of Human Glucocorticoid Receptor β (hGRβ) and Glucocorticoid Resistance
LEWIS‐TUFFIN, L. J., & CIDLOWSKI, J. A. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1351.001 · Cited by 242
Janowsky, D. S., El-Yousef, K. M., & Davis, J. M. (1974) · Psychosomatic Medicine · doi:10.1097/00006842-197405000-00008 · Cited by 230
Miller, A. H., Pariante, C. M., & Pearce, B. D. (1999) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-585-37970-8_7 · Cited by 203 · cited 1×
“Several cytokines and their related signaling pathways can also inhibit glucocorticoid receptor (GR) signaling by downregulating GR translocation and function (60,61).”
BackgroundTh2 Cytokine Response in Major Depressive Disorder Patients before Treatment
Pavón, L., Sandoval-López, G., Eugenia Hernández, M., Loría, F., Estrada, I., Pérez, M., Moreno, J., Ávila, U., Leff, P., Antón, B., et al. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.08.014 · Cited by 187
Asthma and depression: a pragmatic review of the literature and recommendations for future research.
(2005) · Clinical Practice and Epidemiology in Mental Health · doi:10.1186/1745-0179-1-18 · Cited by 164
Wang, X., Wu, H., & Miller, A. H. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001339 · Cited by 128 · cited 1×
“Several cytokines and their related signaling pathways can also inhibit glucocorticoid receptor (GR) signaling by downregulating GR translocation and function (60,61).”
BackgroundShanks, N., & Lightman, S. L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200114592 · Cited by 111
Cardiac and Respiratory Function During Sudden Prolonged Immobility in Wild Rodents
Hofer, M. A. (1970) · Psychosomatic Medicine · doi:10.1097/00006842-197011000-00008 · Cited by 107 · cited 1×
“This work is consistent with reports of increased cholinergic/parasympathetic tone in the experience of hopelessness/depression (49) and forms the basis for Miller and Wood’s model implicating mood in the vagal mediation of pulmonary function (48).”
Result
Cited by
Forsythe, P., Sudo, N., Dinan, T., Taylor, V. H., & Bienenstock, J. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.05.058 · Cited by 429
Self-citationImmune suppression and immune activation in depression
Blume, J., Douglas, S. D., & Evans, D. L. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.10.008 · Cited by 338
Loftis, J. M., Huckans, M., & Morasco, B. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.11.015 · Cited by 252
Emerging comorbidities in adult asthma: risks, clinical associations, and mechanisms
Kankaanranta, H., Kauppi, P., Tuomisto, L. E., & Ilmarinen, P. (2016) · Mediators of Inflammation · doi:10.1155/2016/3690628 · Cited by 122
“during systemic inflammation are able to generate symptoms such as fatigue and loss of appetite that overlap with symptoms of depression [137, 150].”
BackgroundDuivis, H. E., Kupper, N., Vermunt, J. K., Penninx, B. W., Bosch, N. M., Riese, H., Oldehinkel, A. J., & de Jonge, P. (2015) · Health Psychology · doi:10.1037/hea0000210 · Cited by 40
“It is known from the literature that depression and inflammation are both associated with asthma (Van Lieshout, Bienenstock, & MacQueen, 2009), potentially commonly induced by prenatal maternal stress (Van Lieshout et al., 2009).”
Background
Metadata
- Authors
- Van Lieshout, R. J., Bienenstock, J., & MacQueen, G. M.
- Venue
- Psychosomatic Medicine
- Published
- 2009-02
- Volume
- 71
- Issue
- 2
- Pages
- 187-195
- ISSN
- 0033-3174 (ISSN-L)
- OpenAlex
- W2082467732
- Cited by
- 102
- References
- 27
- FWCI
- 2.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.